Meanwhile, in attempts to address long-standing thyroid cancer concerns, a research team conducted a 350,000-person analysis ...

With GLP-1 use rising across the country, major brands are boosting protein, cutting sugar, and reworking formulations and ...

The glucagon-like peptides (GLP-1 and GLP-2) are processed from the proglucagon polypeptide and secreted in equimolar amounts but have opposite effects on chylomicron (CM) production, with GLP-1 ...

Researchers from Japan discover that glucagon-like peptide-2 (GLP-2) analogs can deeply and beneficially reshape the intestinal environment. Short bowel syndrome (SBS) represents one of the most ...

GLP-1 weight loss drugs such as Ozempic and Wegovy have taken the world by storm. But some side effects, from the accepted - ...

Among adolescents with asthma and overweight or obesity, the relative risk for acute asthma exacerbations was significantly reduced with GLP-1 receptor agonist use vs. nonpharmacological weight ...

SYDNEY, AUSTRALIA - JANUARY 13: Ozempic is medicine for adults with type 2 diabetes . Wegovy is prescribed for long-term weight loss in adults and children. Both contain the active ingredient ...

Forbes contributors publish independent expert analyses and insights. Dr. Lipi Roy writes about addiction, mental health and entertainment. The talk of the town at this year’s American Society of ...

Nearly half of seniors quit GLP-1 weight-loss drugs within a year. Experts reveal why older Americans abandon medications like Ozempic and Wegovy despite results.

GLP-1 receptor agonists improve outcomes in patients with coronary plaque and post-STEMI, reducing adverse cardiovascular events and hospitalizations. Patients using GLP-1s show higher event-free ...